Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Jasmine M. Whyte, Ph.D.

Technology Specialist, Patent Agent

New York, NY
212-641-2216
whyte@fr.com
Download vCard
Jasmine M. Whyte, Ph.D. Photo

Background

Jasmine M. Whyte is a Technology Specialist, Patent Agent in the New York office of Fish & Richardson.  Prior to joining the firm, Dr. Whyte (née De Cock) earned her Ph.D. in Biology from Dr. Robert Weinberg’s laboratory at the Whitehead Institute for Biomedical Research/Massachusetts Institute of Technology (M.I.T.), where she investigated the role of inflammation in the awakening of dormant disseminated cancer cells.  Dr. Whyte has experience working in both the pharmaceutical research industry as well as in Academia.  As part of her undergraduate degree at King’s College of London (U.K.), Dr. Whyte was an industrial placement student at Pfizer in Sandwich, U.K., where she worked in a multi-disciplinary group on high-throughput assay development.

Dr. Whyte’s practice focuses on patent prosecution and counseling in the life sciences (including cancer biology, cellular and molecular biology immunology, biochemistry, and molecular genetics).  Dr. Whyte  manages patent portfolios and assists with due diligence and freedom-to-operate studies.  In 2015, Dr. Whyte was an intern in the Boston office of Fish & Richardson as part of the M.I.T. Alumni Association Externship Program.

Education

J.D., Columbia Law School
Expected Graduation 2021


Ph.D., Massachusetts Institute of Technology 2016
Biology


B.S., King's College London 2010
Biochemistry
​Summa Cum Laude


B.A.C., Lycée Pierre de Fermat 2006
​High Honors

Admissions

  • U.S. Patent and Trademark Office 2018

Languages

  • English
  • German
  • French
  • Dutch

Other Distinctions

Publications and Presentations

*Last name was previously De Cock.

Keckesova, Z, Donaher, J.L., De Cock, J., Freinkman, E., Lingrell, S., Bachovchin, D.A., Bierie, B., Tischler, V., Noske, A., Okondo, M.C., Reinhardt, F., Thiru, P., Golub, T.R., Vance, J.E., Weinberg, R.A. LACTB is a tumour suppressor that modulates lipid metabolism and cell state. Nature March 2017: 543(7647): 681-686.

Dance Partners Janssen and Celltrion Face Off in Trial Scheduled for February 2017, co-written with Tasha Francis and Jenny Shmuel, Fish Litigation Blog, February 7, 2017.

De Cock JM, Shibue T, Dongre A, Keckesova Z, Reinhardt F, Weinberg RA. Inflammation triggers Zeb1-dependent escape from tumor latency. Cancer Research 2016 Dec 1;76(23):6778-6784.

Spiegel, A., Brooks, M., Houshyar, S., Reinhardt, F., Ardolino, M., Fessler, E., Chen, M.B., Krall, J.A., De Cock, J., Zervanktonakis, I.K., Iannello, A., Iwamoto, Y., Cortez-Retamozo, V., Kamm, R.D., Pittet, M.J., Raulet, D., Weinberg, R.A.  Neutrophils suppress intraluminal NK-mediated  tumor cell clearance and enhance extravasation of disseminated carcinoma cells Cancer Discov 2016 June; (6): 630-49.

Awards

MIT – Ludwig Graduate Student Fellowship

What's trending with Jasmine